![](https://investorshub.advfn.com/uicon/515354.png?cb=1605015277)
Thursday, March 12, 2020 10:54:56 PM
To answer your question/concern it must be first posed by a question.
What were their clinical trial results?
It's my understanding Algernon's NP-120 reduced fibrosis by 110% over the current best in class.
Furthermore, NP-120 is not a one trick pony.
I have a post here today with NP-120 targeted diseases:
Idiopathic Pulmonary Fibrosis
Acute Lung Injury
Chronic Cough
Influenza
Covid-19
Algernon is on the brink of Prescription & Over-The-Counter medications.
Chronic & Acute.
Hmmm?
OAN: Yeah! Let's get this money-medchem.
/////AMG
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM